As of Apr 24
| -0.11 / -0.75%|
The 9 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 24.00 and a low estimate of 13.00. The median estimate represents a +37.55% increase from the last price of 14.54.
The current consensus among 11 polled investment analysts is to Buy stock in Infinity Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.